All In Biotech

Drug Trial Radar · NCT00237939

A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices

A Prospective, Multicenter, Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices (Broad Effectiveness Trial With Aripiprazole- BETA)

Last checked: Nov 19, 2026Latest source record: Nov 8, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,200

Actual

Start

Sep 2002

Primary completion

Nov 2006

Study completion Nov 2006

Sponsor

Sponsor type
Industry
Collaborators
Otsuka America Pharmaceutical
First posted
Oct 13, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical research study is to evaluate if Aripiprazole will prove to be effective, safe and well tolerated in the treatment of patients with schizophrenia who are treated in a general psychiatric setting.

Conditions

  • Schizophrenia

Interventions

  • AripiprazoleDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Global Impression-Improvement at endpoint

Locations

20 sites in 5 countries. Site status is shown where the registry gives one.

  • Local Institution

    Antwerp, Belgium

  • Local Institution

    Brussels, Belgium

  • Local Institution

    Diest, Belgium

  • Local Institution

    Kortenberg, Belgium

  • Local Institution

    Liège, Belgium

  • Local Institution

    Sint-Michiels, Belgium

  • Local Institution

    Sint-Niklaas, Belgium

  • Local Institution

    Sint-Truiden, Belgium

  • Local Institution

    Tournai, Belgium

  • Local Institution

    Rennes, France

  • Local Institution

    Amersfoort, Netherlands

  • Local Institution

    Raalte, Netherlands

  • Local Institution

    Rotterdam, Netherlands

  • Local Institution

    Barcelos, Portugal

  • Local Institution

    Ceira, Portugal

  • Local Institution

    Coimbra, Portugal

  • Local Institution

    Lisbon, Portugal

  • Local Institution

    Barcelona, Spain

  • Local Institution

    Salamanca, Spain

  • Local Institution

    Seville, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.